Literature DB >> 28614766

Simple obesity and renal function.

D Sikorska1,2, M Grzymislawska3, M Roszak4,5, P Gulbicka6, K Korybalska4, J Witowski4.   

Abstract

Increasing evidence accumulate to suggest that obesity increases the risk of chronic kidney disease independently of dyslipidemia, diabetes, and hypertension. This so-called obesity-related glomerulopathy is characterized at early stages by glomerular hypertrophy with or without secondary focal segmental glomerulosclerosis. Since, however, kidney biopsies are usually not performed at this phase, an early diagnosis of the disease is often difficult. Here, we review new developments in the pathophysiology of obesity-associated kidney dysfunction and discuss the potential of appropriate monitoring of glomerular filtration rate and albuminuria for early detection of the disease. We also present the benefits conferred by even moderate dietary restriction on the course of the disease.

Entities:  

Mesh:

Year:  2017        PMID: 28614766

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  5 in total

Review 1.  Metabolic Syndrome-Related Kidney Injury: A Review and Update.

Authors:  Lirong Lin; Wei Tan; Xianfeng Pan; En Tian; Zhifeng Wu; Jurong Yang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-23       Impact factor: 6.055

2.  Loss of Atg2b and Gskip Impairs the Maintenance of the Hematopoietic Stem Cell Pool Size.

Authors:  Shun-Suke Sakai; Atsushi Hasegawa; Ryosuke Ishimura; Naoki Tamura; Shun Kageyama; Satoko Komatsu-Hirota; Manabu Abe; Yiwei Ling; Shujiro Okuda; Manabu Funayama; Mika Kikkawa; Yoshiki Miura; Kenji Sakimura; Ichiei Narita; Satoshi Waguri; Ritsuko Shimizu; Masaaki Komatsu
Journal:  Mol Cell Biol       Date:  2021-11-08       Impact factor: 4.272

3.  The fat mass, estimated glomerular filtration rate, and chronic inflammation in type 2 diabetic patients.

Authors:  Tomáš Šálek; Alena Adamíková; Petr Ponížil
Journal:  J Clin Lab Anal       Date:  2020-02-11       Impact factor: 2.352

4.  Assessment of the degree of adherence of medical laboratories to KDIGO 2012 guideline for evaluation and management of CKD in Czechia and Slovakia.

Authors:  Šálek Tomáš; Friedecký Bedřich; Kratochvíla Josef; Pelinková Květa; Budina Marek
Journal:  Biochem Med (Zagreb)       Date:  2019-08-05       Impact factor: 2.313

Review 5.  Kidney Damage Caused by Obesity and Its Feasible Treatment Drugs.

Authors:  Meihui Wang; Zixu Wang; Yaoxing Chen; Yulan Dong
Journal:  Int J Mol Sci       Date:  2022-01-11       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.